Food and Drug Administration Information Technology Strategy; Request for Comments; Correction
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Food and Drug Administration (FDA or Agency) is correcting a notice entitled "Food and Drug Administration Information Technology Strategy; Request for Comments" that appeared in the Federal Register of September 19, 2023. The document announced the availability of an information technology (IT) strategic plan entitled the "FDA Information Technology Strategy" and a request for comment on this IT Strategy. The document was published with an incorrect set of fiscal year information. This document corrects that error.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 194 (Tuesday, October 10, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 194 (Tuesday, October 10, 2023)]
[Notices]
[Page 69932]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-22388]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2023-N-3636]
Food and Drug Administration Information Technology Strategy;
Request for Comments; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is correcting
a notice entitled ``Food and Drug Administration Information Technology
Strategy; Request for Comments'' that appeared in the Federal Register
of September 19, 2023. The document announced the availability of an
information technology (IT) strategic plan entitled the ``FDA
Information Technology Strategy'' and a request for comment on this IT
Strategy. The document was published with an incorrect set of fiscal
year information. This document corrects that error.
FOR FURTHER INFORMATION CONTACT: Casi Alexander, Office of Digital
Transformation, Food and Drug Administration, FDA Library, 5630 Fishers
Lane, Rm. 1087, Rockville, MD 20857, 240-402-5171, email:
<a href="/cdn-cgi/l/email-protection#bbf8dac8d295fad7dec3dad5dfdec9fbdddfda95d3d3c895dcd4cd"><span class="__cf_email__" data-cfemail="d596b4a6bcfb94b9b0adb4bbb1b0a795b3b1b4fbbdbda6fbb2baa3">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: In the Federal Register of September 19,
2023 (88 FR 64435), in FR Doc. 2023-20136, the following correction is
made:
On page 64436, in the third column, in the second paragraph,
``Fiscal Years 2024-2026'' is corrected to read ``Fiscal Years 2024-
2027.''
Dated: October 4, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-22388 Filed 10-6-23; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.